Articles

Patients with a noninvasive, low-grade form of bladder cancer often need multiple surgeries to treat recurrences, which are common. A new chemoablative gel currently under study at Penn State Health may eliminate the need for those procedures.
A team of experienced pediatricians and support staff in the Pediatric Complex Care program at Penn State Children’s Hospital collaborates to deliver advanced treatments to patients with multiple chronic illnesses, improving outcomes while helping families overcome socioeconomic and other barriers to care.
Uniting high-level prenatal and surgical care with comprehensive support services, the Perinatal Program at Penn State Health Milton S. Hershey Medical Center and Penn State Children’s Hospital has become the regional referral center for diagnosis and treatment of suspected fetal anomalies.
Specialty-trained surgeons at Penn State Health Milton S. Hershey Medical Center offer the most up-to-date neuromodulation therapy, dorsal root ganglion (DRG) stimulation, to address chronic neuropathic pain that is resistant to other treatment methods.
A newly incorporated, cutting-edge visualization tool is improving the precision of brain and spinal surgeries at Penn State Health Milton S. Hershey Medical Center.
The freshly expanded Neurosurgery Residency Training Program at Penn State Health Milton S. Hershey Medical Center offers world-class training, with the option for future neurosurgeons to complete their education at an accelerated pace.
It requires a remarkable confluence of factors to develop an innovative technology such as the minimally invasive rib fixation system invented by surgeons and other scientists at Penn State Health Milton S. Hershey Medical Center.
With its acquisition of Blue Light Cystoscopy with Cysview in December 2018, the urological team at Penn State Health Milton S. Hershey Medical Center is able to look into the bladder with pinpoint accuracy and immediately remove cancerous lesions that are invisible to the naked eye. More thorough eradication of tumors may reduce recurrence rates and the likelihood that missed cells will develop into more aggressive malignancies.
The Milton S. Hershey Medical Center’s abdominal transplant program provides comprehensive care for central Pennsylvania residents through kidney and liver transplantation and offers deceased and living donor transplantation for both kidney and liver patients. Hershey Medical Center also has the region’s only adult live donor liver transplant and pediatric kidney transplant programs. Expertise in transplantation is available for medical professionals and their patients close to home, without the need to travel to major cities.
The newly renovated Penn State Health St. Joseph Cancer Center in Bern Township delivers innovative oncology services and state-of-the-art technology to area patients so they can receive virtually the entire spectrum of cancer care without the burden of long commutes.
With a significant expansion of researcher-driven clinical trials and a sharp focus on the region’s distinct healthcare needs, Penn State Cancer Institute (PSCI) is bringing the latest in cancer treatments to central Pennsylvania.
By marshaling a collaborative team of specialists and subspecialists at two locations in central Pennsylvania, Penn State Heart and Vascular Institute enables patients with even the most complex cardiovascular conditions to receive innovative, high-level care locally.
Merging the capabilities of MRI and ultrasound technology in real time, Penn State Health Milton S. Hershey Medical Center uses MRI-guided fusion biopsy to more accurately detect the presence and aggressiveness of prostate cancer. This innovative technique facilitates accurate prostate cancer diagnosis while reducing the possibility of nondiagnostic biopsies and the need for repeat procedures.
3D-printed models and implants have revolutionized craniofacial and other reconstructive surgeries at Penn State Health Milton S. Hershey Medical Center, and current research on bioprinting promises even more astonishing advances in treatment.
Two years after adopting the WATCHMAN and MitraClip technologies, WellSpan York Hospital has become a high-volume center for structural heart procedures, fostering excellent outcomes and remarkable levels of patient satisfaction.
Penn State Cancer Institute is the first and only healthcare facility in central Pennsylvania to offer the leading-edge treatment CAR-T cell (CAR-T) therapy to adult patients with lymphoma who have exhausted all other options. Kite Pharma, a division of Gilead, chose just a handful of U.S. facilities for its rollout of the potentially lifesaving treatment, Yescarta, which uses gene editing to boost patients’ own T cells against their cancer.
Cancer treatment summons to mind images of patients passively undergoing chemotherapy or radiation treatment, not actively participating in a program of exercise to alleviate symptoms and enhance outcomes.
Penn State Health St. Joseph Cancer Center integrates tissue-sparing yttrium-90 selective internal radiation therapy (Y-90 SIRT) into treatment of liver cancer, offering many local patients improved outcomes over conventional treatments alone.
Armed with the Flex Robotic System, experienced surgeons at Penn State Health Milton S. Hershey Medical Center can offer patients with human papillomavirus-induced head and neck cancers an advanced, local treatment option that is significantly less invasive than conventional open surgery.
Penn State Health Milton S. Hershey Medical Center’s advanced abdominal wall reconstruction techniques make it a referral destination for complex hernia surgery — even for patients from well beyond the academic medical center’s traditional catchment area.